Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response

Delivery of bone marrow cells (BMCs) to the heart has substantially improved cardiac function in most rodent models of myocardial infarction (MI), but clinical trials of BMC therapy have led to only modest improvements. Rodent models typically involve intra-myocardial injection of BMCs from distinct...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Wang, Xiaoyin, Takagawa, Junya, Lam, Viola C., Haddad, Daniel J., Tobler, Diana L., Mok, Pamela Y., Zhang, Yan, Clifford, Brian T., Pinnamaneni, Kranthi, Saini, Shereen A., Su, Robert, Bartel, Maya J., Sievers, Richard E., Carbone, Larry, Kogan, Scott, Yeghiazarians, Yerem, Hermiston, Michelle L., Springer, Matthew L.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350804/
https://ncbi.nlm.nih.gov/pubmed/21918107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3002814
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items